Live Breaking News & Updates on Abbotsford vic

Stay informed with the latest breaking news from Abbotsford vic on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Abbotsford vic and stay connected to the pulse of your community

Traveller Letters: Sorry Qantas, this is my airline of choice from now on

“After 20 years of being a loyal Qantas flyer, I recently completed both legs of a Japan trip on ANA.”

India , Busan , Pusan-gwangyoksi , South-korea , Australia , Norway , Parkville , New-south-wales , London , City-of , United-kingdom , Dubai

Traveller Letters: Sorry Qantas, this is my airline of choice from now on

Traveller Letters: Sorry Qantas, this is my airline of choice from now on
watoday.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from watoday.com.au Daily Mail and Mail on Sunday newspapers.

Madrid , Spain , Ethiopia , India , Monte-carlo , Toscana , Italy , Surry-hills , New-south-wales , Australia , Norway , Seoul

Starpharma signs DEP® ADC Research Agreement with MSD


Starpharma signs DEP® ADC Research Agreement with MSD
News provided by
Share this article
Starpharma (ASX: SPL,OTCQX: SPHRY) today
announced that is has signed a Research Agreement with MSD, the tradename of
Merck & Co., Inc., Kenilworth NJ USA. Under the agreement, MSD will conduct a preclinical research evaluation of dendrimer based Antibody Drug Conjugates (ADCs) utilising Starpharma's proprietary DEP
® technology.
Dr Jackie Fairley, CEO of Starpharma commented: "MSD is a recognised leader in oncology, and we are delighted to have signed this new Research Agreement in such an innovative and valuable area."
DEP
® ADCs exploit the unique potential of Starpharma's DEP

Australia , Melbourne , Victoria , Kenilworth , Queensland , Nigel-baade , Jackie-fairley , Abbotsford-vic , Herceptin-kadcyla , Merck-co-inc , Astrazeneca , Starpharma-holdings